- Home
- AQST vs CLB Comparison
AQST vs CLB Comparison
Compare AQST & CLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AQST | CLB |
|---|---|---|
| Founded | 2004 | 1936 |
| Country | United States | United States |
| Employees | N/A | 3300 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.4M | 573.6M |
| IPO Year | 2007 | 2023 |
Fundamental Metrics
Financial Performance| Metric | AQST | CLB |
|---|---|---|
| Price | $4.67 | $11.40 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | $9.00 | ★ $12.50 |
| AVG Volume (30 Days) | ★ 2.7M | 353.8K |
| Earning Date | 05-01-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.23% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | $67,430,000.00 | ★ $526,520,000.00 |
| Revenue This Year | $10.08 | N/A |
| Revenue Next Year | $49.60 | $4.75 |
| P/E Ratio | ★ N/A | $109.09 |
| Revenue Growth | ★ 0.77 | 0.51 |
| 52 Week Low | $2.94 | $9.79 |
| 52 Week High | $7.55 | $20.36 |
Technical Indicators
Market Signals| Indicator | AQST | CLB |
|---|---|---|
| Relative Strength Index (RSI) | 51.60 | 44.68 |
| Support Level | $4.03 | $11.62 |
| Resistance Level | $5.10 | $12.27 |
| Average True Range (ATR) | 0.23 | 0.45 |
| MACD | -0.08 | -0.07 |
| Stochastic Oscillator | 23.73 | 35.50 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About CLB Core Laboratories Inc.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.